Literature DB >> 19863172

Thyroid function and its clinical significance in POEMS syndrome.

Xiao-Yi Dun1, Fan Zhou, Hao Xi, Zhen-Gang Yuan, Jian Hou.   

Abstract

POEMS syndrome, also known as Crow-Fukase syndrome, represents a rare multisystem syndrome characterized by polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes. Hypothyroidism is one of the common endocrine abnormalities which are central features of POEMS syndrome. The clinical data associated with the measurement of thyroid function and its clinical significance in POEMS syndrome is still rare. Herein, we report 24 cases with POEMS syndrome which were studied thyroid function and clinical manifestations and performed an associated analysis between hypothyroidism and edema/effusions. Of the 24 patients with POEMS syndrome, 17(70.8%) had a recognized hypothyroidism (including 11 clinical hypothyroidism and 6 subclinical hypothyroidism). Fourteen patients (58.3%) had some form of extravascular volume overload. In 14 patients with edema/effusions, 12 were diagnosed as having hypothyroidism. Hypothyroidism may be one of causes of edema/effusions. After thyroid hormone treatment and chemotherapy, symptoms of hypothyroidism and edema /effusions were improved greatly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19863172     DOI: 10.3109/10428190903324236

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  4 in total

Review 1.  Cytokines in Endocrine Dysfunction of Plasma Cell Disorders.

Authors:  Eva Feigerlová; Shyue-Fang Battaglia-Hsu
Journal:  Mediators Inflamm       Date:  2017-06-27       Impact factor: 4.711

2.  Characteristics of 1946 Cases of POEMS Syndrome in Chinese Subjects: A Literature-Based Study.

Authors:  Yong Wang; Li-Bo Huang; Yi-Hua Shi; Huan Fu; Zhen Xu; Guo-Qing Zheng; Yan Wang
Journal:  Front Immunol       Date:  2019-06-21       Impact factor: 7.561

3.  Subclinical Hypothyroidism in TAFRO Syndrome.

Authors:  Satoko Oka; Kazuo Ono; Masaharu Nohgawa
Journal:  Intern Med       Date:  2019-06-07       Impact factor: 1.271

4.  Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements.

Authors:  Satoko Oka; Kazuo Ono; Masaharu Nohgawa
Journal:  Clin Case Rep       Date:  2018-02-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.